A carregar...
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
Tumors are the foremost cause of death worldwide. As a result of that, there has been a significant enhancement in the investigation, treatment methods, and good maintenance practices on cancer. However, the sensitivity and specificity of a lot of tumor biomarkers are not adequate. Hence, it is of i...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018836/ https://ncbi.nlm.nih.gov/pubmed/33833800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5512524 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|